• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Impact Factor leap for Psychiatry Karger journal — home of innovation

Bioengineer by Bioengineer
July 6, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

According to the Journal Citation Reports (JCR) recently released by Clarivate Analytics, the Impact Factor of the Journal Psychotherapy and Psychosomatics has increased from 8.964 to 13.122 in 2017. This takes the rank of the journal to the fifth position of 142 journals in total in the subject area Psychiatry of the SCI.

"This journal is a home for innovation. We focus on choosing articles for the journal that represent new ideas," is the explanation of Editor-in-Chief Professor Giovanni Andrea Fava for this significant improvement. Over the last few years, Psychotherapy and Psychosomatics has anticipated and developed new lines of research in psychosomatic medicine, psychotherapy research and psychopharmacology. The journal features editorials and reviews on current and controversial issues at the interface between medical and behavioral sciences.

"For Psychotherapy and Psychosomatics, we have decided to give priority to submissions of high methodological quality that may provide new clinical insights. Of course, not every idea is followed by developments and gains acceptance. But we are happy to take a chance. I am thankful for the freedom and the trust of our publishing house," emphasizes Fava.

"Primarily, the increase of the Impact Factor of Psychotherapy and Psychosomatics reflects the excellent job of our Editor-in-Chief Giovanni Fava and the editorial board for this journal," says Gabriella Karger, Vice Chairwoman and Publisher.

The journal was founded in 1953 as Psychotherapeutica et Psychosomatica by E.A.D.E. and continued in 1965 as Psychotherapy and Psychosomatics at Karger Publishers. Giovanni Andrea Fava has been Editor-in-Chief of the journal since 1992.

###

About Karger Publishers

Karger Publishers in Basel, Switzerland, is a globally active medical and scientific publishing company. Independent and family-run in the fourth generation by Vice Chairwoman and Publisher Gabriella Karger and Chairman Thomas Karger, the company is dedicated to serving the information needs of the scientific community with publications of high-quality content, covering all fields of medical science. The publication program comprises 50 new books per year and 108 peer-reviewed journals with a growing number of open access publications. Karger content is published predominantly in English, with a strong focus on basic and clinical research, and is generally available online. S. Karger AG consists of the publishing company Karger Publishers (est. 1890) and the International Subscription Agency Karger Libri (est. 1960).

Further information about Karger Publishers: http://www.karger.com

Media Contact

Sophie Saberi
[email protected]
41-613-061-352
@KargerPublisher

http://www.karger.com

Share12Tweet8Share2ShareShareShare2

Related Posts

Metabolic Signatures Link VAT Mass to Liver Disease

April 1, 2026

SOCS5 Links DNA Damage to Diabetic Retinopathy

April 1, 2026

In Vivo Parkinson’s Histology via Quantitative Mapping

April 1, 2026

Adiposity Changes Impact Hypertension Differently by Life Stage

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

DNA Damage Drives Selective CUX2 Neuron Loss

Metabolic Signatures Link VAT Mass to Liver Disease

SOCS5 Links DNA Damage to Diabetic Retinopathy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.